Chengdu Ucello Biotechnology Co., Ltd.
Clinical trials sponsored by Chengdu Ucello Biotechnology Co., Ltd., explained in plain language.
-
Radical cell therapy tested for lupus patients out of options
Disease control Not yet recruitingThis early-stage study is testing a new type of treatment called CD19/BCMA CAR-T cell therapy for adults with severe systemic lupus erythematosus (lupus) that hasn't responded to standard treatments. The main goals are to check the treatment's safety, find the best dose, and see …
Phase: EARLY_PHASE1 • Sponsor: Chengdu Ucello Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New cell therapy trial targets Tough-to-Treat cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have a specific marker called Claudin18.2. The main goals are to see if the treatment is safe and if it can shrink tumors. Participants will have their own immune …
Phase: EARLY_PHASE1 • Sponsor: Chengdu Ucello Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC